Lupin Limited, a Mumbai-based pharmaceutical company, has launched, through a partnership with Eli Lilly and Company, Lilly’s Cialis (tadalafil), an oral phosphodiesterase Type 5 inhibitor, for the treatment of erectile dysfunction in adult males.

Lupin has acquired the rights to market, promote ,and distribute Cialis through its specialty field force while Lilly will be responsible for manufacturing and importing the product.

Lupin is also partnered with Lilly for other products. Lupin is already promoting and distributing Lilly’s Huminsulin range of products and rapid -acting insulin analog under the brand names Lispro and Eglucent.

Source: Lupin